お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、薬物放出粒子の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に薬物放出粒子市場を分類しています。
本レポートでは世界の薬物放出粒子市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Biocompatibles、BTG International、Merit Medical Systems、CeloNova BioSciences、ABK Biomedical、Boston Scientific、Medtronic、Merit Medical Systems、Surefire Medical、Terumo

レポートは薬物放出粒子の主要生産者を調査し、主要地域や国の消費状況も提供します。薬物放出粒子の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Oncozene Beads
    Quadra Sphere
    LC Beads
    Others

用途別の市場セグメント：
    Hospitals
    Specialized Clinics
    Research Centers
    Ambulatory Surgical Centers

本レポートの詳細内容
本レポートは、世界の薬物放出粒子市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて薬物放出粒子市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の薬物放出粒子生産量、成長率、市場シェアを調査している。

二. 消費面では、薬物放出粒子の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの薬物放出粒子売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の薬物放出粒子市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本薬物放出粒子のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：薬物放出粒子のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 薬物放出粒子の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける薬物放出粒子の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章薬物放出粒子メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：薬物放出粒子の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：薬物放出粒子の主要メーカーの概要を提供し、製品の説明と仕様、薬物放出粒子の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：薬物放出粒子の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global Drug Eluting Beads market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Drug Eluting Beads, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drug Eluting Beads, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Drug Eluting Beads, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Eluting Beads sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Drug Eluting Beads market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Drug Eluting Beads sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Merit Medical Systems and Surefire Medical, etc.

Market Segmentation
By Company
    Biocompatibles
    BTG International
    Merit Medical Systems
    CeloNova BioSciences
    ABK Biomedical
    Boston Scientific
    Medtronic
    Merit Medical Systems
    Surefire Medical
    Terumo

Segment by Type
    Oncozene Beads
    Quadra Sphere
    LC Beads
    Others

Segment by Application
    Hospitals
    Specialized Clinics
    Research Centers
    Ambulatory Surgical Centers

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drug Eluting Beads in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Drug Eluting Beads manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Eluting Beads sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Drug Eluting Beads Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Oncozene Beads
    Table 3. Major Manufacturers of Quadra Sphere
    Table 4. Major Manufacturers of LC Beads
    Table 5. Major Manufacturers of Others
    Table 6. Global Drug Eluting Beads Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Drug Eluting Beads Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Drug Eluting Beads Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Drug Eluting Beads Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Drug Eluting Beads Revenue Market Share by Region (2019-2024)
    Table 11. Global Drug Eluting Beads Revenue Market Share by Region (2025-2030)
    Table 12. Global Drug Eluting Beads Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Drug Eluting Beads Sales by Region (2019-2024) & (K Units)
    Table 14. Global Drug Eluting Beads Sales by Region (2025-2030) & (K Units)
    Table 15. Global Drug Eluting Beads Sales Market Share by Region (2019-2024)
    Table 16. Global Drug Eluting Beads Sales Market Share by Region (2025-2030)
    Table 17. Global Drug Eluting Beads Sales by Manufacturers (2019-2024) & (K Units)
    Table 18. Global Drug Eluting Beads Sales Share by Manufacturers (2019-2024)
    Table 19. Global Drug Eluting Beads Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Drug Eluting Beads Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Drug Eluting Beads, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Drug Eluting Beads Price by Manufacturers 2019-2024 (USD/Unit)
    Table 23. Global Drug Eluting Beads Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Drug Eluting Beads by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Beads as of 2023)
    Table 25. Global Key Manufacturers of Drug Eluting Beads, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Drug Eluting Beads, Product Offered and Application
    Table 27. Global Key Manufacturers of Drug Eluting Beads, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Drug Eluting Beads Sales by Type (2019-2024) & (K Units)
    Table 30. Global Drug Eluting Beads Sales by Type (2025-2030) & (K Units)
    Table 31. Global Drug Eluting Beads Sales Share by Type (2019-2024)
    Table 32. Global Drug Eluting Beads Sales Share by Type (2025-2030)
    Table 33. Global Drug Eluting Beads Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Drug Eluting Beads Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Drug Eluting Beads Revenue Share by Type (2019-2024)
    Table 36. Global Drug Eluting Beads Revenue Share by Type (2025-2030)
    Table 37. Drug Eluting Beads Price by Type (2019-2024) & (USD/Unit)
    Table 38. Global Drug Eluting Beads Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 39. Global Drug Eluting Beads Sales by Application (2019-2024) & (K Units)
    Table 40. Global Drug Eluting Beads Sales by Application (2025-2030) & (K Units)
    Table 41. Global Drug Eluting Beads Sales Share by Application (2019-2024)
    Table 42. Global Drug Eluting Beads Sales Share by Application (2025-2030)
    Table 43. Global Drug Eluting Beads Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Drug Eluting Beads Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Drug Eluting Beads Revenue Share by Application (2019-2024)
    Table 46. Global Drug Eluting Beads Revenue Share by Application (2025-2030)
    Table 47. Drug Eluting Beads Price by Application (2019-2024) & (USD/Unit)
    Table 48. Global Drug Eluting Beads Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 49. US & Canada Drug Eluting Beads Sales by Type (2019-2024) & (K Units)
    Table 50. US & Canada Drug Eluting Beads Sales by Type (2025-2030) & (K Units)
    Table 51. US & Canada Drug Eluting Beads Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Drug Eluting Beads Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Drug Eluting Beads Sales by Application (2019-2024) & (K Units)
    Table 54. US & Canada Drug Eluting Beads Sales by Application (2025-2030) & (K Units)
    Table 55. US & Canada Drug Eluting Beads Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Drug Eluting Beads Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Drug Eluting Beads Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Drug Eluting Beads Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Drug Eluting Beads Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Drug Eluting Beads Sales by Country (2019-2024) & (K Units)
    Table 61. US & Canada Drug Eluting Beads Sales by Country (2025-2030) & (K Units)
    Table 62. Europe Drug Eluting Beads Sales by Type (2019-2024) & (K Units)
    Table 63. Europe Drug Eluting Beads Sales by Type (2025-2030) & (K Units)
    Table 64. Europe Drug Eluting Beads Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Drug Eluting Beads Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Drug Eluting Beads Sales by Application (2019-2024) & (K Units)
    Table 67. Europe Drug Eluting Beads Sales by Application (2025-2030) & (K Units)
    Table 68. Europe Drug Eluting Beads Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Drug Eluting Beads Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Drug Eluting Beads Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Drug Eluting Beads Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Drug Eluting Beads Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Drug Eluting Beads Sales by Country (2019-2024) & (K Units)
    Table 74. Europe Drug Eluting Beads Sales by Country (2025-2030) & (K Units)
    Table 75. China Drug Eluting Beads Sales by Type (2019-2024) & (K Units)
    Table 76. China Drug Eluting Beads Sales by Type (2025-2030) & (K Units)
    Table 77. China Drug Eluting Beads Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Drug Eluting Beads Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Drug Eluting Beads Sales by Application (2019-2024) & (K Units)
    Table 80. China Drug Eluting Beads Sales by Application (2025-2030) & (K Units)
    Table 81. China Drug Eluting Beads Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Drug Eluting Beads Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Drug Eluting Beads Sales by Type (2019-2024) & (K Units)
    Table 84. Asia Drug Eluting Beads Sales by Type (2025-2030) & (K Units)
    Table 85. Asia Drug Eluting Beads Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Drug Eluting Beads Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Drug Eluting Beads Sales by Application (2019-2024) & (K Units)
    Table 88. Asia Drug Eluting Beads Sales by Application (2025-2030) & (K Units)
    Table 89. Asia Drug Eluting Beads Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Drug Eluting Beads Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Drug Eluting Beads Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Drug Eluting Beads Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Drug Eluting Beads Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Drug Eluting Beads Sales by Region (2019-2024) & (K Units)
    Table 95. Asia Drug Eluting Beads Sales by Region (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Drug Eluting Beads Sales by Type (2019-2024) & (K Units)
    Table 97. Middle East, Africa and Latin America Drug Eluting Beads Sales by Type (2025-2030) & (K Units)
    Table 98. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Drug Eluting Beads Sales by Application (2019-2024) & (K Units)
    Table 101. Middle East, Africa and Latin America Drug Eluting Beads Sales by Application (2025-2030) & (K Units)
    Table 102. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Drug Eluting Beads Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Drug Eluting Beads Sales by Country (2019-2024) & (K Units)
    Table 108. Middle East, Africa and Latin America Drug Eluting Beads Sales by Country (2025-2030) & (K Units)
    Table 109. Biocompatibles Company Information
    Table 110. Biocompatibles Description and Major Businesses
    Table 111. Biocompatibles Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 112. Biocompatibles Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Biocompatibles Recent Developments
    Table 114. BTG International Company Information
    Table 115. BTG International Description and Major Businesses
    Table 116. BTG International Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 117. BTG International Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. BTG International Recent Developments
    Table 119. Merit Medical Systems Company Information
    Table 120. Merit Medical Systems Description and Major Businesses
    Table 121. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 122. Merit Medical Systems Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Merit Medical Systems Recent Developments
    Table 124. CeloNova BioSciences Company Information
    Table 125. CeloNova BioSciences Description and Major Businesses
    Table 126. CeloNova BioSciences Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 127. CeloNova BioSciences Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. CeloNova BioSciences Recent Developments
    Table 129. ABK Biomedical Company Information
    Table 130. ABK Biomedical Description and Major Businesses
    Table 131. ABK Biomedical Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 132. ABK Biomedical Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. ABK Biomedical Recent Developments
    Table 134. Boston Scientific Company Information
    Table 135. Boston Scientific Description and Major Businesses
    Table 136. Boston Scientific Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 137. Boston Scientific Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Boston Scientific Recent Developments
    Table 139. Medtronic Company Information
    Table 140. Medtronic Description and Major Businesses
    Table 141. Medtronic Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 142. Medtronic Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Medtronic Recent Developments
    Table 144. Merit Medical Systems Company Information
    Table 145. Merit Medical Systems Description and Major Businesses
    Table 146. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 147. Merit Medical Systems Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Merit Medical Systems Recent Developments
    Table 149. Surefire Medical Company Information
    Table 150. Surefire Medical Description and Major Businesses
    Table 151. Surefire Medical Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 152. Surefire Medical Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Surefire Medical Recent Developments
    Table 154. Terumo Company Information
    Table 155. Terumo Description and Major Businesses
    Table 156. Terumo Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 157. Terumo Drug Eluting Beads Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Terumo Recent Developments
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. Drug Eluting Beads Distributors List
    Table 162. Drug Eluting Beads Customers List
    Table 163. Drug Eluting Beads Market Trends
    Table 164. Drug Eluting Beads Market Drivers
    Table 165. Drug Eluting Beads Market Challenges
    Table 166. Drug Eluting Beads Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug Eluting Beads Product Picture
    Figure 2. Global Drug Eluting Beads Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Drug Eluting Beads Market Share by Type in 2023 & 2030
    Figure 4. Oncozene Beads Product Picture
    Figure 5. Quadra Sphere Product Picture
    Figure 6. LC Beads Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Drug Eluting Beads Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Drug Eluting Beads Market Share by Application in 2023 & 2030
    Figure 10. Hospitals
    Figure 11. Specialized Clinics
    Figure 12. Research Centers
    Figure 13. Ambulatory Surgical Centers
    Figure 14. Drug Eluting Beads Report Years Considered
    Figure 15. Global Drug Eluting Beads Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Drug Eluting Beads Revenue 2019-2030 (US$ Million)
    Figure 17. Global Drug Eluting Beads Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global Drug Eluting Beads Revenue Market Share by Region (2019-2030)
    Figure 19. Global Drug Eluting Beads Sales 2019-2030 ((K Units)
    Figure 20. Global Drug Eluting Beads Sales Market Share by Region (2019-2030)
    Figure 21. US & Canada Drug Eluting Beads Sales YoY (2019-2030) & (K Units)
    Figure 22. US & Canada Drug Eluting Beads Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Drug Eluting Beads Sales YoY (2019-2030) & (K Units)
    Figure 24. Europe Drug Eluting Beads Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. China Drug Eluting Beads Sales YoY (2019-2030) & (K Units)
    Figure 26. China Drug Eluting Beads Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Asia (excluding China) Drug Eluting Beads Sales YoY (2019-2030) & (K Units)
    Figure 28. Asia (excluding China) Drug Eluting Beads Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America Drug Eluting Beads Sales YoY (2019-2030) & (K Units)
    Figure 30. Middle East, Africa and Latin America Drug Eluting Beads Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. The Drug Eluting Beads Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 32. The Top 5 and 10 Largest Manufacturers of Drug Eluting Beads in the World: Market Share by Drug Eluting Beads Revenue in 2023
    Figure 33. Global Drug Eluting Beads Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 34. Global Drug Eluting Beads Sales Market Share by Type (2019-2030)
    Figure 35. Global Drug Eluting Beads Revenue Market Share by Type (2019-2030)
    Figure 36. Global Drug Eluting Beads Sales Market Share by Application (2019-2030)
    Figure 37. Global Drug Eluting Beads Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Drug Eluting Beads Sales Market Share by Type (2019-2030)
    Figure 39. US & Canada Drug Eluting Beads Revenue Market Share by Type (2019-2030)
    Figure 40. US & Canada Drug Eluting Beads Sales Market Share by Application (2019-2030)
    Figure 41. US & Canada Drug Eluting Beads Revenue Market Share by Application (2019-2030)
    Figure 42. US & Canada Drug Eluting Beads Revenue Share by Country (2019-2030)
    Figure 43. US & Canada Drug Eluting Beads Sales Share by Country (2019-2030)
    Figure 44. U.S. Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe Drug Eluting Beads Sales Market Share by Type (2019-2030)
    Figure 47. Europe Drug Eluting Beads Revenue Market Share by Type (2019-2030)
    Figure 48. Europe Drug Eluting Beads Sales Market Share by Application (2019-2030)
    Figure 49. Europe Drug Eluting Beads Revenue Market Share by Application (2019-2030)
    Figure 50. Europe Drug Eluting Beads Revenue Share by Country (2019-2030)
    Figure 51. Europe Drug Eluting Beads Sales Share by Country (2019-2030)
    Figure 52. Germany Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 53. France Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 54. U.K. Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 55. Italy Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 56. Russia Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 57. China Drug Eluting Beads Sales Market Share by Type (2019-2030)
    Figure 58. China Drug Eluting Beads Revenue Market Share by Type (2019-2030)
    Figure 59. China Drug Eluting Beads Sales Market Share by Application (2019-2030)
    Figure 60. China Drug Eluting Beads Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Drug Eluting Beads Sales Market Share by Type (2019-2030)
    Figure 62. Asia Drug Eluting Beads Revenue Market Share by Type (2019-2030)
    Figure 63. Asia Drug Eluting Beads Sales Market Share by Application (2019-2030)
    Figure 64. Asia Drug Eluting Beads Revenue Market Share by Application (2019-2030)
    Figure 65. Asia Drug Eluting Beads Revenue Share by Region (2019-2030)
    Figure 66. Asia Drug Eluting Beads Sales Share by Region (2019-2030)
    Figure 67. Japan Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 68. South Korea Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 69. China Taiwan Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 70. Southeast Asia Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 71. India Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America Drug Eluting Beads Sales Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Drug Eluting Beads Revenue Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Drug Eluting Beads Sales Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Drug Eluting Beads Revenue Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Drug Eluting Beads Revenue Share by Country (2019-2030)
    Figure 77. Middle East, Africa and Latin America Drug Eluting Beads Sales Share by Country (2019-2030)
    Figure 78. Brazil Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 79. Mexico Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 80. Turkey Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 81. Israel Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 82. GCC Countries Drug Eluting Beads Revenue (2019-2030) & (US$ Million)
    Figure 83. Drug Eluting Beads Value Chain
    Figure 84. Drug Eluting Beads Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed